Genome Canada will develop a strategic plan and its investments will undergo a strategic review in conjunction with Industry Canada as it sets the stage for a second five-year mandate. The federal Budget issued the directives along with $60 million in bridge funding to the arm’s length agency to tide it over for another year and the end of its first five-year funding agreement, ending March 31/05.